DISCLOSURE UNDER REGULATION 29(2) OF SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS, 2011
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mr. Sudhir Sethi, a main promoter of Beryl Drugs Ltd, acquired 800 equity shares (0.02% of total capital) through market transactions on 20-03-2026. His holding in the company increased from 4,78,183 shares (9.42%) to 4,78,983 shares (9.44%). The disclosure is filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The total equity share capital of the company stands unchanged at 50,71,700 shares. Part-B of the disclosure also lists other promoters — Sanjay Sethi, Sangita Sethi, and Soniya Sethi — as persons acting in concert.
This is a very small open-market purchase by a promoter and is unlikely to have any meaningful impact on the stock price. It signals modest promoter confidence but represents a routine, minor increase in promoter holding, still well below any major regulatory threshold.